These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24018262)

  • 61. Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.
    Meulbroek JA; Oleksijew A; Tanaka SK; Alder JD
    J Antimicrob Chemother; 1996 Oct; 38(4):641-53. PubMed ID: 8937959
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis.
    Mehla K; Ramana J
    OMICS; 2016 Nov; 20(11):635-644. PubMed ID: 27753544
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.
    Khan DD; Lagerbäck P; Malmberg C; Kristoffersson AN; Wistrand-Yuen E; Sha C; Cars O; Andersson DI; Hughes D; Nielsen EI; Friberg LE
    Int J Antimicrob Agents; 2018 Mar; 51(3):399-406. PubMed ID: 29127049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli.
    Wang J; Guo ZW; Zhi CP; Yang T; Zhao JJ; Chen XJ; Zeng L; Lv LC; Zeng ZL; Liu JH
    J Antimicrob Chemother; 2017 May; 72(5):1293-1302. PubMed ID: 28160469
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Contribution of QnrA, a Plasmid-Mediated Quinolone Resistance Peptide, to Survival of Escherichia coli Exposed to a Lethal Ciprofloxacin Concentration.
    Goto K; Kawamura K; Arakawa Y
    Jpn J Infect Dis; 2015; 68(3):196-202. PubMed ID: 25672356
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
    Le Menestrel A; Guerin F; Chau F; Massias L; Benchetrit L; Cattoir V; Fantin B; de Lastours V
    J Antimicrob Chemother; 2021 Dec; 77(1):155-163. PubMed ID: 34718597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain.
    Mobley HL; Jarvis KG; Elwood JP; Whittle DI; Lockatell CV; Russell RG; Johnson DE; Donnenberg MS; Warren JW
    Mol Microbiol; 1993 Oct; 10(1):143-55. PubMed ID: 7968511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.
    Michon A; Allou N; Chau F; Podglajen I; Fantin B; Cambau E
    PLoS One; 2011; 6(9):e24552. PubMed ID: 21915350
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ciprofloxacin resistance in E. coli isolated from turkeys in Great Britain.
    Gosling RJ; Clouting CS; Randall LP; Horton RA; Davies RH
    Avian Pathol; 2012; 41(1):83-9. PubMed ID: 22845325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The association between occurrence of plasmid-mediated quinolone resistance and ciprofloxacin resistance in Escherichia coli isolates of different origins.
    Yang T; Zeng Z; Rao L; Chen X; He D; Lv L; Wang J; Zeng L; Feng M; Liu JH
    Vet Microbiol; 2014 May; 170(1-2):89-96. PubMed ID: 24553411
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.
    Gales AC; Gordon KA; Wilke WW; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):61-4. PubMed ID: 10744370
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC.
    Briales A; Rodríguez-Martínez JM; Velasco C; Díaz de Alba P; Domínguez-Herrera J; Pachón J; Pascual A
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1266-9. PubMed ID: 21173174
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance.
    Akter F; Amin MR; Osman KT; Anwar MN; Karim MM; Hossain MA
    World J Microbiol Biotechnol; 2012 Mar; 28(3):827-34. PubMed ID: 22805801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants.
    Jurado S; Orden JA; Horcajo P; De La Fuente R; Ruiz-Santa-Quiteria JA; Martínez-Pulgarín S; Domínguez-Bernal G
    J Vet Diagn Invest; 2008 May; 20(3):342-5. PubMed ID: 18460623
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA.
    Shaheen BW; Nayak R; Foley SL; Boothe DM
    J Antimicrob Chemother; 2013 May; 68(5):1019-24. PubMed ID: 23302578
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.
    Park CH; Robicsek A; Jacoby GA; Sahm D; Hooper DC
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3953-5. PubMed ID: 16954321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center.
    Canawati HN; el-Farra R; Seymour J; Shimashita J; Dunn D; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):133-8. PubMed ID: 9401805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.